S3460-119

In Committee

PFAS Accountability Act of 2025

119th Congress Introduced Dec 11, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill creates a federal cause of action and medical monitoring remedy for people significantly exposed to PFAS.

Who Benefits and How

Individuals significantly exposed to PFAS could gain a direct path to sue responsible manufacturers and users and seek medical monitoring remedies.

Who Bears the Burden and How

PFAS manufacturers and users could face new litigation exposure and potential medical monitoring liability.

Key Provisions

  • States the Act's purposes of PFAS accountability and medical monitoring.
  • Creates a federal cause of action for significant PFAS exposure.
  • Allows medical monitoring and related remedies for significantly exposed individuals.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

This bill creates a federal cause of action and medical monitoring remedy for people significantly exposed to PFAS.

Key Policy Areas

Environment, Healthcare

Primary Purpose

This bill creates a federal cause of action and medical monitoring remedy for people significantly exposed to PFAS.

Policy Domains

Environment Healthcare

Main Provisions

Identified Gains
Contextual inference, no direct clause citation
  • Individuals significantly exposed to PFAS
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • PFAS manufacturers and users facing the new cause of action and remedies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is

Contextual inference, no direct clause citation

Legislative Progress

In Committee
Introduced Committee Passed
Dec 11, 2025

Read twice and referred to the Committee on Environment and …

Dec 11, 2025

Introduced in Senate

Dec 11, 2025

Mrs. Gillibrand introduced the following bill; which was read twice …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

General Public
2 mentions across 2 clauses
+2 positive

Individuals significantly exposed to PFAS who may bring claims and seek medical monitoring

Manufacturing
2 mentions across 2 clauses
-2 negative

PFAS manufacturers and users facing new federal litigation and medical monitoring liability

3/5
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Environment Healthcare

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology